Carter Alyssa M, Woods Emily C, Bogyo Matthew
Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Curr Opin Chem Biol. 2025 Jun;86:102596. doi: 10.1016/j.cbpa.2025.102596. Epub 2025 Apr 19.
Microbial pathogens continue to plague human health and develop resistance to our current frontline treatments. Over the last few decades, there has been limited development of antibiotics with new mechanisms of action, highlighting our need to identify processes that can be targeted by next generation therapeutics. Recent advancements in our understanding of the roles that lipids play in key bacterial processes suggest that these biomolecules are a potentially valuable site for disruption by therapeutic agents. Specifically, the success of a pathogen depends on its ability to make fatty acids de novo or scavenge lipids from its host. This review focuses on recent advances using chemical biology tools for defining and disrupting lipid pathways in bacteria.
微生物病原体持续困扰人类健康,并对我们目前的一线治疗产生耐药性。在过去几十年里,具有新作用机制的抗生素开发有限,这凸显了我们识别可被下一代治疗药物靶向的过程的必要性。我们对脂质在关键细菌过程中所起作用的理解最近取得了进展,这表明这些生物分子是治疗剂破坏的潜在有价值靶点。具体而言,病原体的成功取决于其从头合成脂肪酸或从宿主获取脂质的能力。本综述重点介绍了利用化学生物学工具定义和破坏细菌脂质途径的最新进展。